Print

Helix BioMedix, Inc. (HXBM) Reports Second Quarter 2012 Financial Results; Launches New Apothedermâ„¢ Acne Clarifying Treatment  
8/3/2012 10:27:53 AM

BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the second quarter ended June 30, 2012.
//-->